Headlines about Dynatronics (NASDAQ:DYNT) have been trending somewhat positive on Wednesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Dynatronics earned a news impact score of 0.15 on Accern’s scale. Accern also assigned media coverage about the medical equipment provider an impact score of 47.1852236992467 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Dynatronics (NASDAQ DYNT) traded down $0.03 during trading on Wednesday, hitting $2.65. 13,000 shares of the stock traded hands, compared to its average volume of 20,157. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.62 and a quick ratio of 0.83. Dynatronics has a fifty-two week low of $2.10 and a fifty-two week high of $3.75.
Separately, Zacks Investment Research upgraded shares of Dynatronics from a “hold” rating to a “buy” rating and set a $3.00 target price for the company in a research note on Tuesday, December 5th.
In other news, major shareholder Ventures 1 Lp Provco purchased 300,000 shares of the stock in a transaction dated Thursday, November 30th. The stock was acquired at an average price of $2.50 per share, for a total transaction of $750,000.00. Following the completion of the transaction, the insider now owns 586,944 shares of the company’s stock, valued at $1,467,360. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, major shareholder Stuart Essig purchased 27,455 shares of the stock in a transaction dated Wednesday, January 3rd. The shares were purchased at an average price of $2.77 per share, with a total value of $76,050.35. Following the transaction, the insider now directly owns 856,169 shares of the company’s stock, valued at approximately $2,371,588.13. The disclosure for this purchase can be found here. Insiders have bought 369,015 shares of company stock valued at $930,372 in the last 90 days. Insiders own 51.80% of the company’s stock.
Dynatronics Company Profile
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.